Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies

Abstract

Read online

Keywords

• tigecycline
• cefoperazone/sulbactam
• carbapenems
• β-lactam antibiotics
• coagulation disorders
• hypofibrinogenaemia